Mark Avagliano - Net Worth and Insider Trading
Mark Avagliano Net Worth
The estimated net worth of Mark Avagliano is at least $500,205 dollars as of 2024-05-08. Mark Avagliano is the Chief Business Officer of G1 Therapeutics Inc and owns about 117,834 shares of G1 Therapeutics Inc (GTHX) stock worth over $500,205. Details can be seen in Mark Avagliano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Avagliano has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).
Transaction Summary of Mark Avagliano
Mark Avagliano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Avagliano owns 1 companies in total, including G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of Mark Avagliano’s form 4 insider trades.
Insider Ownership Summary of Mark Avagliano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-01-04 | Chief Business Officer |
Mark Avagliano Latest Holdings Summary
Mark Avagliano currently owns a total of 1 stock. Mark Avagliano owns 117,834 shares of G1 Therapeutics Inc (GTHX) as of January 4, 2024, with a value of $500,205.
Latest Holdings of Mark Avagliano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-01-04 | 117,834 | 4.25 | 500,205 |
Holding Weightings of Mark Avagliano
Mark Avagliano Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Avagliano has made a total of 2 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 4,081 shares on January 4, 2024, which brought Mark Avagliano around $12,610.
Insider Trading History of Mark Avagliano
- 1
Mark Avagliano Trading Performance
Mark Avagliano Ownership Network
Mark Avagliano Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Mark Avagliano is the Chief Business Officer of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Medical Officer Rajesh Malik , and Chief Operating Officer Terry L Murdock .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Mark Avagliano made 1 insider transaction in G1 Therapeutics Inc (GTHX) with a net sale of 4,081. Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 69,908 shares made by Rajesh Malik , a net sale of 85,014 shares made by Bailey John E. (jack) Jr. , and a net sale of 7,469 shares made by Terry L Murdock .
In summary, during the past 3 months, insiders sold 35,147 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 35,147 shares. During the past 18 months, 242,086 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 242,086 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Mark Avagliano Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Avagliano. You might contact Mark Avagliano via mailing address: 79 T.w. Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
